All In Biotech

Drug Trial Radar · NCT05835895

Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis

A Phase 1b, Randomized, Double-Blinded, Placebo-Controlled Dose Ranging Study to Evaluate Safety, Tolerability and Pharmacodynamics of a Single Intra-articular Injection of GNSC-001 Gene Therapy in Subjects With Osteoarthritis of the Knee

Last checked: Nov 20, 2026Latest source record: Aug 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

67

Actual

Start

Jun 12, 2023

Primary completion

Apr 8, 2025

Study completion May 2029

Sponsor

Lead sponsor
Genascence CorporationIndustry
Sponsor type
Industry
Collaborators
California Institute for Regenerative Medicine (CIRM)
First posted
Apr 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical study is to determine if a single injection of 1 or more dose levels of adeno-associated virus (AAV) gene therapy (GNSC-001) is safe and tolerated compared to placebo in participants with painful osteoarthritis (OA) of the knee.

Conditions

  • Osteoarthritis, Knee
  • Osteo Arthritis Knee
  • Knee Osteoarthritis

Interventions

  • GNSC-001Genetic

    intra-articular injection

  • transient immune-modulationDrug

    oral

  • transient immune-modulationDrug

    intra-articular injection

  • PlaceboDrug

    intra-articular injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs)Time frame: Month 12
  2. Severity of TEAEs and SAEsTime frame: Month 12

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Alliance for Medical Research Mobile

    Mobile, Alabama

  • Biosolutions Clinical Research Center

    La Mesa, California

  • UC San Diego

    San Diego, California

  • Well Pharma Medical Research

    Miami, Florida

  • South Florida Research

    Miami Springs, Florida

  • Premier Medical Associates

    The Villages, Florida

  • Alliance for Multispecialty Research Kansas City

    Kansas City, Missouri

  • West Clinical Research

    Morehead City, North Carolina

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.